![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 17, 12789-12798, April 28, 2000
§,
,
,
,
, and
**
From the
Department of Microbiology and Immunology,
State University of New York, Health Science Center at
Brooklyn, New York 11203, the ¶ Department of Microbiology,
University of Connecticut Health Center,
Farmington, Connecticut 06030, and the
Rockefeller University,
New York, New York 10021
| |
ABSTRACT |
|---|
|
|
|---|
The transcript cleavage factors GreA and GreB of
Escherichia coli are involved in the regulation of
transcription elongation. The surface charge distribution analysis of
their three-dimensional structures revealed that the N-terminal domains
of GreA and GreB contain a small and large basic "patch,"
respectively. To elucidate the functional role of basic patch, mutant
Gre proteins were engineered in which the size and charge distribution
of basic patch were modified and characterized biochemically. We found
that Gre mutants lacking basic patch or carrying basic patch of
decreased size bind to RNA polymerase and induce transcript cleavage
reaction in minimally backtracked ternary elongation complex (TEC) with the same efficiency as the wild type factors. However, they exhibit substantially lower readthrough and cleavage activities toward extensively backtracked and arrested TECs and display decreased efficiency of photocross-linking to the RNA 3'-terminus. Unlike wild
type factors, basic patch-less Gre mutants are unable to complement the
thermosensitive phenotype of
GreA-:GreB- E. coli strain. The
large basic patch is required but not sufficient for the induction of
GreB-type cleavage reaction and for the cleavage of arrested TECs. Our
results demonstrate that the basic patch residues are not directly
involved in the induction of transcript cleavage reaction and suggest
that the primary role of basic patch is to anchor the nascent RNA in
TEC. These interactions are essential for the readthrough and
antiarrest activities of Gre factors and, apparently, for their
in vivo functions.
Prokaryotic transcript cleavage factors GreA and GreB and
eukaryotic transcription elongation factor TFIIS
(SII)1 affect the efficiency
of transcription elongation in vitro by stimulating the
intrinsic endonucleolytic activity of RNA polymerases (RNAPs) (1-8).
The endonucleolytic hydrolysis of the nascent RNA has been observed in
transcription elongation complexes (TECs) of multisubunit bacterial (9,
10) and viral RNAPs (11) and in eukaryotic RNAP I, II, and III (4-7,
12, 13). SII-like factors have been found in viruses (14),
archaebacteria (15), yeast (16), insects (17), and mammals (18, 19),
whereas the genes encoding GreA and GreB have been identified in more than 30 different bacterial organisms (see Fig. 1). The ubiquity of
transcript cleavage factors in nature underscores their biological importance. Although gre and SII genes are not essential for
cell viability, the deletion of these genes in Escherichia
coli and S. cerevisiae renders them sensitive to
certain growth conditions, such as elevated temperatures (10) or the
presence of 6-azauracil (20).
The factor-stimulated cleavage of RNA occurs 2-18 bases upstream from
the 3'-terminus, followed by dissociation of the 3'-proximal fragment
from TEC. The 5'-proximal fragment of the transcript remains in TEC and
can be extended in the presence of rNTPs. GreA induces hydrolysis of
predominantly di- and trinucleotides (type A cleavage activity),
whereas SII and GreB induce cleavage of 2-18-nucleotide-long RNA
fragments (type B cleavage activity) (2, 3, 21, 22). In the absence of
factors, the endonucleolytic activity of RNAP can be induced by
pyrophosphate (23) or at alkaline pH (10), indicating that the same
active center of RNAP is responsible for the cleavage reaction, as well
as for pyrophosphorolysis and RNA synthesis reactions. The precise
molecular mechanism by which Gre factors activate the endonucleolytic
activity of RNAP is not known.
The cleavage reaction mediated by Gre and SII factors is believed to be
an integral part of the mechanism that allows RNAP to overcome
obstacles encountered during elongation in vivo, such as
pausing and arresting sites in the DNA sequences, nucleosomes, or
DNA-binding proteins and drugs (6, reviewed in Ref. 24). Although there
are no direct in vivo data to support this, many in
vitro studies have shown that SII and GreB can rescue arrested TECs (2-7, 9, 24) in which RNAP has irreversibly "backtracked" along the DNA template. Backtracking of RNAP occurs when it is forced
to stall during elongation and results in backward translocation of
RNAP with simultaneous repositioning of its catalytic center from the
3'-terminus to an internal site of the transcript (25-27). The
cleavage of 3'-terminal segment of RNA induced by GreB and SII in
arrested TEC allows RNAP to restart transcription from a newly
generated 3'-terminus, which is now properly aligned with its catalytic
center ("antiarrest activity") (2-6, 28). Unlike GreB, GreA is
unable to induce cleavages in preformed arrested TECs and to reactivate
them (1, 2, 21). However, GreA and GreB were shown to prevent
elongating TECs from falling into an arrested conformation
("readthrough activity") (1, 2). The functional selectivity of GreA
may be related to its ability to induce cleavage of only short RNAs.
Besides readthrough/antiarrest function, the factor-induced transcript
cleavage reaction may play a part in the mechanisms that regulate
transcription fidelity (29-31) and transition of RNAP from initiation
to elongation stage of transcription (32).
According to the established three-dimensional structures, GreA and
GreB of E. coli share a similar overall structural
organization (33, 34) that consists of an N-terminal coiled-coil domain (NTD) and a C-terminal globular domain (CTD). The NTD is responsible for the induction of type-specific nucleolytic activity by Gre factors
(34, 35), whereas the CTD is responsible for the high affinity binding
of Gre factors to RNAP (34-37). The charge distribution analysis of
three-dimensional structures revealed a cluster of positively charged
residues on NTD of GreA and GreB that form a distinct structural
feature, described as basic "patch," on the side of the protein
that is presumed to face RNAP in TEC. The basic patch residues of all
known GreA and GreB molecules are highly conserved (Fig. 1). The
photocross-linking experiments performed on various TECs have
demonstrated that the 3'-terminus of RNA is located in the immediate
vicinity of basic patch on both Gre proteins (33, 34), implicating
basic patch in the functional interaction of Gre proteins with RNA in
TEC. Additionally, the lengths of basic patch on GreA and GreB, ~7
and ~35 Å, respectively, were noted to correlate with the maximum
lengths of RNA fragments that can be excised from TEC in the presence
of Gre factors: 2-3 nucleotides for GreA and up to 18 nucleotides for
GreB. Finally, it was observed that in the absence of factors, the
nucleolytic activity of RNAP can be stimulated at a mildly alkaline pH,
which mimics the effect of GreA (at pH 8.5-9.5) and GreB (at pH above 10.0) (10).
Based on these observations, two alternative hypotheses were proposed
for the role of basic patch in Gre function: first, the basic patch
residues increase the local pH near the active site of RNAP and
directly affect its catalytic properties; second, they bind the nascent
RNA by electrostatic interaction, thereby facilitating the cleavage
reaction and determining the size of cleavage product. To test these
hypotheses, we introduced a series of mutations in Gre proteins that
would result in altered size and charge distribution of basic patch.
The functional properties of mutant proteins were analyzed in
vivo and in vitro. The results that we present rule out
the first hypothesis and support the second, suggesting that the role
of basic patch is to bind the 3'-terminal portion of the nascent RNA
and to maintain it in proper orientation in TEC. Based on our results,
we conclude that Gre-RNA interactions mediated through basic patch are
essential for the readthrough and antiarrest functions of Gre factors
in vitro and for their activity in vivo.
Strains and Plasmids--
E. coli
greA-greB- strain AD8571
( Oligonucleotides--
The following oligonucleotides were used
for polymerase chain reaction mutagenesis (underlined nucleotides
define the restriction sites of the enzymes shown in parentheses;
mutagenized residues of GreA and GreB are shown italicized): 1)
5'-GGTCGCCATGCTCAGCCGCTTCCGCGATAGC-3' (GreA-R37A, DdeI); 2)
5'-ACCCTGCTGTTCAGCAGCTGCGTGGTATTCGGC-3'(GreA-R52A, PvuII); 3)
5'-GCGCGTTCGACAGCTTTTTTTCGATATCTTTAATACGGCGTTCGCAGAA-3' (GreA: G60R/A67K, EcoRV); 4)
5'-TTCGCAGAAGCGCTGCTGTTTACGAGCTGCGTGG-3' (GreA-E53K/G56R, HaeII); 5)
5'-GATTTCACGCAGACGTGCTGCATTATACTGATAGTC-3' (GreB-K52/53A, MaeII); 6)
5'-GTGAGATAGCGCACGCGAGCGTCGATTTCAGCCAGACGTGCTGCATTATA-3' (GreB-R56A/R60A, HgaI); 7)
5'-GAGATTTTCCAGGCACGCAGTGAGATAGCGCAC-3' (GreB-K67A, DraIII); 8)
5'-GGCACGCAGTGAGATAGGCCACGCGATCGTCGATTTCATCCAGACGTGCTGC ATTATA-3' (GreB-R56D/R60D, PvuI). Four
additional oligos corresponding to the 3'- and 5'-terminal portions of
wt greA and wt greB with C-terminal His6 tag were also used
as described previously (34).
Preparation of Mutant GreA and GreB Proteins--
All
gre mutants were obtained by a conventional two-step
polymerase chain reaction procedure as described (34) using an appropriate combination of one of the mutagenic oligos (oligos 1-8)
and one of oligos corresponding to the flanking region of greA and greB genes (2, 38). The resulting DNA
fragments containing gre genes with a desirable mutation (or
mutations) were inserted into either pTRC99A (GreA-37A, -52A, and -BPL)
or PET-19b (GreA-LBP2, -LBP3, -LBP4, and all GreB mutants) vector using
appropriate restriction sites (34, 35). The resulting expression
plasmids (see Table I) carrying mutant gre genes were transformed into
E. coli greA-greB In Vitro Transcription Assays--
The readthrough, antiarrest,
and transcript cleavage assays were performed as described previously
(49) using 202 bp E. coli rrnB P1 DNA fragment with the
initial transcribed sequence +1CACCAUGACACGGA
Quantitative RNA-Gre photocross-linking assay was performed using
radiolabeled 9A-TEC carrying either 8-N3AMP at the RNA
3'-terminus or N3-NPA-UMP at position +7 of the transcript
as described (34, 35). The samples were analyzed by Tris-Tricine
SDS-16%-PAGE (50) followed by autoradiography and quantification using
a PhosphorImager.
In Vivo Temperature Sensitivity (ts) Complementation
Assay--
The
greA-/greB- E. coli cells (strain AD8571) transformed with pTRC99A, pDKA37A,
pDKA52A, pDKABPL, pMO1.1, or pMO1.4His were grown at 30 °C in LB
medium containing 150 µg/ml ampicillin and 0.3% glucose to an
absorbance of 0.35 at 600 nm. Five 10-fold dilutions of each strain
were made, and 5 µl of each sample were plated (in triplicate) on
LB-agar plates containing 100 µg/ml ampicillin and either 0.3%
glucose or IPTG at various concentrations. The plates were incubated at
30 or 42 °C for 36 or 18 h, respectively. The remaining liquid
culture of each strain was diluted three times with LB-medium, grown,
and induced with different concentrations of IPTG (see below and in the
legend to Fig. 5 for details). An aliquot of each culture was analyzed
for Gre expression by SDS-PAGE.
Construction and Expression of Gre Mutants--
Among 34 prokaryotic organisms of which the partial or complete genomes have
been sequenced to date and made available in the NCBI data bank, all
but two possess the genes that encode homologs of GreA, GreB, or both.
Fig. 1 shows the amino acid sequence alignment of the N-terminal half of 33 GreA and 13 GreB proteins. Although the overall homology shared between different Gre proteins varies from 21 to 95%, the residues that make up the basic patch in
E. coli GreA (Arg37 and Arg52) and
GreB (Lys52, Lys53, Arg56,
Arg60, and Lys67) are highly conserved (Fig.
1). Specifically, three out of six basic patch residues of GreB are
invariant among 13 organisms. A few exceptions reside in
greA genes of Clostridium acetobutylicum, Deinococcus radiodurans, Chlamydia trachomatis, and
Treponema pallidum, in which the highly conserved
Arg37 or Arg52 is changed to leucine or
isoleucine, and in greB genes of Pseudomonas aeruginosa and Shewanella putrefaciens, in which the
conserved Arg60 is changed to serine. These observations
suggest that not all of the residues making up the basic patch may be
necessary for in vivo activities of Gre factors.
To investigate the functional role of basic patch in E. coli
GreA and GreB, and to assess the contribution of basic patch residues
to the characteristic properties of Gre factors, the residues
Arg37 and Arg52 of GreA and Lys52,
Lys53, Arg56, Arg60, and
Lys67 of GreB were substituted by site-directed polymerase
chain reaction mutagenesis to alanine individually, in groups of
spatially adjacent residues, or altogether, yielding BPL GreA and GreB
mutants (Table I). Four additional
mutants were made by substitution of specific residues to generate GreA
carrying increasingly large basic patch (GreA-LBP2, -LBP3, and -LBP4)
and GreB carrying an acidic patch on the basic patch-less background
(GreB-BPL5-DD) (Table I). Basic patch residues of GreA and GreB are
located on the surface of NTD and are not involved in intramolecular
and interdomain interactions. Therefore, mutations of these residues
are expected not to affect the folding of Gre molecules. Indeed, the
chromatographic behavior of purified mutant proteins during
size-exclusion high pressure liquid chromatography and their apparent
binding affinity to RNAP holoenzyme tested by Gre-RNAP competition
binding assay (34) were indistinguishable from those of wt GreA and
GreB (data not shown).
Quantitative in Vitro Analysis of BPL Gre Mutants--
To
characterize the functional properties of mutant Gre proteins, we used
three types of quantitative in vitro transcription assays
based on E. coli ribosomal rrnB P1 transcription
unit (51). First, a specific transcript cleavage assay was used to test
the ability of Gre mutants to induce nucleolytic reactions in minimally backtracked 7U-TEC, extensively backtracked 9A- and 10C-TECs, and
arrested (irreversibly backtracked) 12C/13G-TEC (1, 2). These TECs
differ by the extent to which RNAP is backtracked from the RNA
3'-terminus (1-2, 2-4, 3-5, and 7-8 nucleotides, respectively). Second, the specific Gre-RNA interactions were analyzed by
photocross-linking assay using a photoactive probe with a short (~2
Å) space arm, 8-azido-AMP, placed at the RNA 3'-terminus in 9A-TEC
(33, 34). Third, a readthrough assay was used to examine the ability of mutant proteins to help RNAP to read through intrinsic arresting sites
on rrnB P1 template at positions +12 and +13, and prevent the formation of arrested 12C- and 13G-TECs during elongation (49). The
results of these experiments are summarized in Fig. 2.
Transcript Cleavage Assays--
Single and multiple alanine
substitutions of basic patch residues and the introduction of acidic
patch (GreB-BPL5-DD) did not affect the specific transcript cleavage
activity of mutant proteins toward 7U-TEC (Fig. 2B, open
bars). Thus, the basic patches of GreA or GreB are not responsible
for activation of the nucleolytic center in RNAP. However, compared
with the wt factors, the cleavage activity of mutant proteins toward
9A- and 10C-TECs significantly decreased (Fig. 2B, light
gray and dark gray bars, respectively). The effect of
mutations was more pronounced for GreA, in which each individual Ala
substitution caused a 10-fold decrease in cleavage activity toward both
TECs and in which double mutation (GreA-BPL) resulted in 30- and
200-fold decreases toward 9A- and 10C-TECs, respectively. The basic
patch mutations in GreB caused a moderate (3-8-fold) loss of cleavage
activity for both TECs, except for GreB-BPL5-DD, in which the decrease
was more substantial (15- and 50-fold, respectively). These results
show that multiple mutations of basic patch residues in both Gre
proteins have an additive effect on the overall loss of cleavage
activity toward 9A- and 10C-TECs. The most striking effect of mutations
was observed in the cleavage assay using arrested 12C/13G-TECs (Fig.
2B, black bars). As expected, unlike GreB, which was shown
to be highly active toward arrested TECs (2, 21), the wt GreA and its mutant variants were completely inactive in this assay. For GreB, the
Ala substitution of two basic patch residues at the tip of NTD (K52A
and K53A: GreB-BPL2) resulted in a 15-fold decrease in cleavage
activity toward arrested 12C/13G-TECs. Further mutations of
Arg56 and Arg60 at the center of the basic
patch (GreB-BPL4) caused an additional 7-fold decrease, leading to an
overall loss of cleavage activity by a factor of ~100. The Ala
substitution of the last basic patch residue, Lys67, at the
top of NTD (GreB-BPL5) resulted in an additional 2-fold decrease in
cleavage activity, making this mutant 200 times less active than the wt
GreB. Finally, GreB-BPL5-DD carrying two acidic residues,
Asp56 and Asp60, in the center of basic
patch-less NTD, showed no detectable cleavage activity (more than
5000-fold decrease in activity).
In addition to concentration-dependence assays, for each Gre protein,
we also performed the time course analyses of transcript cleavage
reaction toward all TECs studied. For the wild type Gre factors and
their corresponding BPL mutants (all used at 1 nM), the
rates of cleavage reactions toward 7U-TEC (used at 2.5 nM) were similar. However, the Gre-BPL mutants displayed progressively decreased rates of cleavage reactions toward 9A-, 10C-, and
12C/13G-TECs relative to the wt factors (data not shown). These results
were consistent with conclusions drawn from analyses of the specific cleavage activities of Gre mutants using assays described above.
Gre-RNA Photocross-linking Assay--
GreA and GreB have been
shown to cross-link to the nascent RNA 3'-terminus in 9A-TEC. Their
cross-linking efficiencies differ by a factor of ~30, in favor of
GreB (34). Compared with the wt factors, the efficiency of mutant
protein cross-linking to the RNA 3'-terminal photoactive probe in
9A-TEC (Fig. 2C, light gray bars) decreased for
GreA mutants in the order GreA Specific Transcriptional Readthrough Assay--
The readthrough
assay is based on the ability of wt GreA and GreB to suppress the
transcriptional arrest of RNAP during elongation in several promoter
systems in vitro (1, 2). When the initial radiolabeled
6C-TEC obtained on rrnB P1 template is allowed to elongate
in the presence of NTPs, ~50% of the complexes that do not reach the
end of the template becomes arrested at positions +12C and +13G. The
presence of GreA or GreB at the beginning of transcription elongation
significantly (~10-20-fold) reduces the formation of arrested TECs
and increases the amount of the runoff product (1, 2). As reported
earlier (34), the specific readthrough activity of GreB, expressed in
relative units/µg of Gre protein, was ~10 times higher than that of
GreA (Fig. 2C, black bars). Interestingly, in this assay,
the decrease in the specific readthrough activities of mutants compared
with the wt factors followed the same order as the decrease in their
cross-linking efficiencies: GreA Analysis of the Type of Cleavage Activity of BPL Gre
Mutants--
Next, we tested the hypothesis that basic patch functions
as a molecular ruler to determine the maximum length of RNA to be excised from TEC, and is thus directly responsible for conferring A- or
B-type specific cleavage activities to Gre factors. We analyzed the
BPL-mutants in qualitative transcript cleavage assay (49) using 9A- and
10C-TECs carrying radiolabeled transcripts CpApCpCpApCpUpGpA and CpApCpCpApCpUpGpApC, respectively. In reversibly
backtracked 9A and 10C-TECs, the wt GreA stimulates cleavage and
release of dinucleotide pGpA and trinucleotide
pGpApC, respectively (type A cleavage activity), whereas the
wt GreB predominantly induces the cleavage of tetranucleotide
pCpUpGpA and pentanucleotide pCpUpGpApC,
respectively (type B cleavage activity) (2). Thus, in the assay using
9A- and 10C-TECs, the type of products generated define the GreA- or
GreB-type activity. The results obtained from comparative analyses of
BPL-mutants and wt Gre proteins using these criteria are shown in Fig.
3. The removal of one or both basic
residues from GreA (GreA52A, GreA37A, and GreA-BPL) did not affect the
type specificity of the cleavage reaction either in 9A-TEC (Fig.
3A, lanes 3-6) or in 10C-TEC (data not shown). However, the
stepwise reduction of the basic patch in GreB (GreB-BPL2, -BPL4, and
-BPL5 mutants) led to a gradual decrease in the length of excised
3'-terminal RNA fragment in 9A-TEC from tetranucleotide to tri- and
dinucleotide (Fig. 3A, lanes 7-10), and in 10C-TEC from
pentanucleotide to tetra- and trinucleotide (Fig. 3B, lanes 2-5). The most striking effect was observed in GreB-BPL5-DD
mutant, which, like GreA, stimulated cleavages of only di- and
trinucleotides (Fig. 3A, lane 11, and Fig. 3B, lane
6). These results demonstrate that basic patch residues of GreB
determine the type of cleavage activity characteristic for this factor
and that decreasing the size of its basic patch switches its activity
from B to A type.
In Vitro Analysis of GreA Mutants Carrying Large Basic
Patch--
To test whether the size and charge of basic patch alone
determine the functional properties of Gre factors, we analyzed GreA mutants carrying increasingly large basic patch in in vitro
transcription assays (Fig.
4A). As shown in Fig.
4B, none of GreA-LBP mutants gained the ability of the wt
GreB to induce transcript cleavage reactions in arrested 12C/13G-TECs
(black bars). Moreover, whereas the introduction of two basic residues,
Arg60 and Lys67, into GreA (GreA-LBP2) only
slightly affected its functional activities, the additional
substitutions of Glu53 to Arg (GreA-LBP3) and
Gly56 to Lys (GreA-LBP4) caused a substantial (50-80-fold)
decrease in transcript cleavage activity toward 7U, 9A-, and 10C-TECs
(Fig. 4B, open, light gray, and dark gray bars,
respectively). Furthermore, the readthrough activity of GreA-LBP3 and
-LBP4 mutants decreased by factors of ~15 and ~50, respectively,
making the latter mutant, which carries the largest basic patch,
totally inactive in the readthrough assay (Fig. 4C, black
bars). At the same time, the efficiency of GreA-LBP3 and -LBP4
cross-linking to the RNA 3'-terminal probe in 9A-TEC increased 3- and
15-fold, respectively, over that of wt GreA (Fig. 4C,
light gray bars). Again, the stronger effect was observed in
GreA-LBP4, the photocross-linking efficiency of which was similar to
that of the wt GreB.
These results demonstrate that the enlargement of basic patch on the
surface of NTD in GreA leads to an increased attraction of RNA
3'-terminus, apparently through nonspecific electrostatic interactions.
The increase in Gre-RNA binding by itself, however, is not sufficient
to confer GreB-like properties to GreA. Moreover, the loss of
transcript cleavage and readthrough activities by GreA-LBP mutants
(especially LBP4) suggests that the basic residues introduced at
positions 53 and 56 of GreA (E53R and G56K mutations) distort the local
structure of NTD and disrupt its normal contacts with RNAP and RNA.
Therefore, it appears that stronger but less specific Gre-RNA
interactions are detrimental to the functional activity of a Gre
protein. Similar functional defect has previously been observed
in posttranslationally modified GreB. Under conditions of limited
proteolysis, wt GreB can be selectively cleaved by endoproteinase AspN
at Asp47, which is located at the tip of NTD near the loop
connecting two In Vivo Analysis of GreA and GreB Mutants with Decreased Basic
Patch--
To assess the role of basic patch in the in vivo
function of Gre factors and to correlate them with their in
vitro activities, we subjected Gre mutants to an in vivo
ts complementation assay. The assay is based on the ability
of wt greA or greB genes, under conditions of low
level expression from a pTRC99A expression vector, to complement the ts
phenotype of the
greA-/greB- E. coli strain (10). The results of in vivo assay for GreA mutants with decreased basic patch are shown in Fig.
5.
Without IPTG induction, there is low but detectable expression of wt
and mutant GreA proteins from the leaky trc promoter of pTRC99A (Fig.
5A, lanes 2, 6, 10, and 14). Under
these conditions, the intracellular concentration of Gre proteins was
~5 µM according to the quantitative immunoblotting
performed with anti-GreA antibodies (data not shown), about 3-4 times
the natural concentration of GreA in the parental wild type E. coli cells (35). At a permissive temperature (30 °C), growth of
greA-/greB- E. coli cells was not affected by the presence of any Gre protein (Fig. 5B, panel a). However, at a nonpermissive
temperature (42 °C), the basal level expression of wt GreA provided
full viability to the cells, whereas double mutant GreA-BPL or vector
alone did not (Fig. 5B, panel d). Under the same conditions,
the expression of single mutants GreA-37A and GreA-52A resulted in
moderately and weakly positive phenotypes, respectively.
The induction of cells with 0.03 mM IPTG resulted in about
~8-fold increase in Gre expression (Fig. 5A, lanes
3, 7, 11, and 15), reaching an estimated intracellular
concentration of about 40 µM. In contrast to control
cells carrying vector alone, the elevated expression of the wt GreA, as
well as all mutant factors, was sufficient to complement the
ts phenotype of
greA-/greB- E. coli cells at 42 °C (Fig. 5B, panel e),
without affecting the cell growth at 30 °C (panel b).
Next, the expression of Gre factors in the presence of 0.1 mM or 0.3 mM IPTG resulted in an ~40-fold
increase of Gre synthesis compared with uninduced cells (Fig.
5A, lanes 4, 5, 8, 9, 12, 13, 16, and
17). Under these conditions, the overexpression of wt GreA
became highly toxic to the cells and led to a lethal phenotype at both
permissive and nonpermissive temperatures (Fig. 5B, panels c
and f, respectively). Unlike wt GreA, and to a lesser extent
unlike each single GreA mutant, the overproduction of double mutant
GreA-BPL was much less toxic for the cells grown at 30 °C, and
moreover, this mutant was able to confer viability to cells grown at
42 °C. At the same time, GreA-37A and GreA-52A mutants displayed
weak and moderate complementation phenotypes, respectively, conferring
partial viability to the cells at a nonpermissive temperature. These
observations suggest that complementation of the ts
phenotype of
greA-/greB- E. coli cells at 42 °C requires 24-32 times higher concentration of GreA-BPL mutant than the minimal working concentration of the wt
factor. Mutations of each residue of the basic patch contribute to the
loss of in vivo activity by GreA-BPL, although GreA-37A mutant appears to be more active than GreA-52A mutant under conditions of low expression and becomes much more toxic when overexpressed. The
loss of in vivo activity by GreA-BPL mutants correlated with the general decrease in their in vitro readthrough and
transcript cleavage activities toward backtracked TECs and their
ability to cross-link to nascent RNA (see Fig. 3).
Due to the leakiness of trc promoter, only nontoxic Gre mutants with
moderate functional defects could be analyzed using this system. The
attempt to clone GreA-LBP3, GreA-LBP4, GreB-BPL4, GreB-BPL5, and
GreB-BPL5-DD mutants into pTRC99A plasmid failed due to the appearance
of secondary null mutations.2
However, the fact that the low-level expression of mutant GreB factors
was toxic even in the presence of chromosomal copies of wt
gre genes suggests that mutations in basic patch of GreB
caused severe functional defect, resulting in a dominant negative
phenotype in vivo. Therefore, we conclude that the basic
patch residues of GreA and GreB indeed play an essential role in the
in vivo functions of these factors.
Previous biochemical studies have implicated the NTD of Gre
proteins in the functional interactions of Gre with RNA in TECs (33,
34), the induction of nucleolytic activity of RNAP (35), and the
antiarrest/readthrough activities of Gre proteins (34). In this work,
we investigated the role of basic patch residues of NTD in biochemical
activities of GreA and GreB in vitro and correlate it with
the in vivo functions of Gre factors.
Our functional assays showed that the removal of basic patch, or even
the introduction of acidic patch, does not affect the ability of Gre
protein to induce cleavage in 7U-TEC but affects its cleavage activity
in 9A- and 10C-TEC and significantly impairs the activity toward
arrested 12/13-TEC (Fig. 2B). These results clearly
demonstrate that the residues of basic patch are not responsible for
directly influencing the catalytic residues of RNAP, the way alkaline
pH might be thought to stimulate the endonuclease activity of RNAP.
Apparently, some other amino acid residues of NTD are responsible for
this function. However, the presence of basic patch residues is
required in GreA and GreB for the induction of RNA cleavage in
extensively backtracked and arrested TECs.
A gradual reduction in the size of basic patch results in a
corresponding decrease in the efficiency of RNA-Gre cross-linking in
TEC and in readthrough/antiarrest activities of Gre factors (Fig.
2C). The diminution of basic patch in GreB decreases the length of the excised 3'-terminal RNA fragment and results in gradual
conversion of its activity from GreB type to GreA type (Fig. 3). These
observations indicate that the basic patch residues are involved in
specific electrostatic interactions with the exposed 3'-terminal
portion of the nascent transcript in backtracked TECs. We propose that
these interactions provide the internal phosphodiester bond of RNA a
proper orientation and alignment toward RNAP catalytic center and
facilitate the cleavage reaction. Increasing the size of basic patch on
GreA, on the other hand, results in aberrantly strong RNA-Gre
interactions and loss of cleavage and readthrough activity by GreA
(Fig. 4). This result emphasizes the critical role of the specificity
of RNA-Gre interactions required in the induction of nucleolytic
activity of RNAP. It also implies that despite their apparent
structural similarity, GreA and GreB may not interact with TEC in an
entirely superimposable manner.
Above results are consistent with the "molecular ruler" hypothesis,
which posits that the maximum length of cleaved RNA fragment is
determined by the size of basic patch in Gre proteins. However, according to our results, the length of cleavage product and the efficiency of cleavage reaction are also governed by the extent of TEC
backtracking. In minimally backtracked 7U-TEC, for instance, in which
the catalytic center is 1-2 nucleotides in distance away from RNA
3'-terminus, the wt GreA, GreB, and all Gre BPL mutants, including
GreB-BPL5-DD, induce cleavage of only dinucleotides and display similar
specific cleavage activities (Fig. 2B). Thus, in minimally
backtracked TECs, basic patch does not act as molecular ruler, and
moreover, the basic patch residues are dispensable for the induction of
cleavage reaction. We interpret these results to mean that in minimally
backtracked TEC, tight Gre-RNA interactions are not required for
efficient transcript cleavage reaction. As the extent of backtracking
increases in 9A-, 10C-, and 12C/13G-TECs, the active center of RNAP
moves further from the 3'-terminus of RNA (4-8 nucleotides), and an
increasingly large 3'-terminal portion of RNA becomes extruded in TEC
(25, 26).3 Under these
conditions, the size of basic patch is shown to be a determining factor
in the length of cleavage products (Fig. 3) and in the efficiency of
cleavage reaction (Fig. 2B). In other words, in extensively
backtracked and arrested TECs, the strength and specificity of Gre-RNA
interactions play an essential role in the transcript cleavage reaction.
It should be noted that besides the basic patch residues, other
surface-exposed residues of NTD may contribute to specific interactions
with RNA. This follows from the observation that GreA-BPL and GreB-BPL
mutants still display a low-level cross-linking to RNA and possess a
residual antiarrest/readthrough function, whereas the introduction of
acidic patch into GreB-BPL5 (GreB-BPL5-DD) abolishes both activities
(Fig. 2, B and C).
Gre-RNA interactions most likely constitute a necessary step in the
readthrough and antiarrest activities mediated by GreA and GreB. We
envision that the finger-like NTD of Gre protein acts as a linker that
holds the transcript in a fixed location relative to RNAP active site.
This is possible because Gre itself is secured to RNAP through its CTD.
By physically anchoring the RNA 3'-terminus to their basic patch, Gre
factors prevent stalled (or paused) TEC from backtracking, or
backtracking further. The specific NTD-RNA interactions serve another
important function: they prime the internal phosphodiester bond of RNA
for an efficient cleavage reaction. Thus, by promoting cleavage and
resynthesis of RNA at the onset of backtracking, Gre factors increase
the overall odds for elongation and, conversely, decrease the
probability of continued backtracking, which may lead to
transcriptional arrest. The Gre proteins lacking basic patch are unable
to secure RNA and are therefore required at higher concentration than
wt Gre to achieve the same efficiency of cleavage reaction. This
explains why Gre BPL factors display low readthrough activity (Fig.
2C). Similar mechanism may be at work during abortive
initiation of transcription cycle; by inducing cleavage, Gre factors
may prevent RNAs from dissociating from the initiation complex.
Increasing the time of RNA occupancy in the initiation complex may play
a crucial role in facilitating the transition of RNAP from initiation to elongation stage of transcription (32). Preliminary data demonstrate
that GreA-BPL indeed exhibits reduced ability to promote transition
from initiation to elongation both in vivo and in
vitro (data not shown).
Our views on Gre-RNAP and Gre-RNA interactions in TECs that resulted
from in vitro studies of Gre-BPL mutants are generally consistent with recently published crystal structure of Thermus aquaticus RNAP (53) and with electron microscopy studies of the
binding site of the Gre factor on E. coli RNAP reported
earlier (36). On the one hand, the CTD of Gre factor binds to the
solvent exposed surface of the RNAP molecule next to but not in the
~25-27-Å internal channel, which is thought to be occupied by
double-stranded DNA and RNA-DNA hybrid, and at a distance of about 30 Å away from the location of the active site (36, 53). Furthermore, the interaction of Gre protein with RNAP appears to occur near the opening
of the 10-12-Å-wide secondary channel, which is presumed to provide
access to the NTP substrates to the active center (53). Because the
minimum width of the NTD of GreA and GreB is about 14-16 Å (33), any
insertion of the Gre N-terminal domain through secondary channel and
direct interactions with the catalytic residues of the RNAP active
center are unlikely on structural grounds. On the other hand, the
3'-terminal end of the nascent RNA may only be able to interact with
Gre proteins if it protrudes through the secondary channel in the
backtracked TEC (53). This interaction may be possible if the NTD of
Gre factor occupies a corridor, near the opening of the secondary
channel, formed by an extended coiled-coil subdomain of Finally, we show that under low level of expression, BPL Gre factors
are unable to complement the ts phenotype of
GreA Interestingly, eukaryotic transcription elongation factor TFIIS, the
functional homolog of Gre, lacks any structural or sequence homology
with GreA or GreB (56, 57). However, similar to Gre factors, SII
interacts with nascent RNA in TEC (58). Moreover, within the zinc
ribbon domain of SII, which is functionally similar to NTD of Gre
factors, basic and aromatic residues that are critical for SII
functions are also implicated in electrostatic and stacking interactions with RNA or RNA-DNA hybrid (59, 60). These data suggest
that specific interactions between transcript cleavage factors and
nascent RNA play an important role in regulation of both prokaryotic
and eukaryotic transcription elongation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(ompR-greB), greA::KanR derivative of E. coli SG480
76 strain (10)) was used for overexpression of Gre
proteins, for preparation of GreA/GreB-free RNAP, and for in
vivo studies. pTRC99A (Amersham Pharmacia Biotech) was used as an
expression vector for construction of plasmids overproducing the wild
type (wt) GreA, wt GreB, and mutant basic patch-less (BPL) GreA
factors. pET19B (Novagen) was used as an expression vector for
GreA-large basic patch 3 (GreA-LBP3), GreA-LBP4, and all GreB mutants
(Table I). The plasmid pMO1.1 carrying the wt greA gene and
the plasmid pMO1.4His carrying the wt greB gene with
C-terminal hexahistidine tag were used as templates for polymerase chain reaction preparation of the target greA and
greB mutants, respectively (34). Because alteration of basic
patch was expected to disrupt specific functions of Gre proteins, the
cloning and selection of plasmids carrying mutant gre genes
were performed in E. coli XL-Blue cells (Stratagene) in
GreA+/GreB+-background to minimize the
occurrence of spontaneous secondary null mutations. The DNA sequences
were verified by dideoxy chain termination sequencing of the double
stranded plasmid DNA.
strain AD8571. The growth and
isopropyl-
-D-thiogalactopyranoside (IPTG) induction of
the cells carrying derivatives of pTRC99A was performed as described
(34). The cells transformed with PET-19b derivatives were grown and
infected with phage
(CE6) carrying phage T7 RNA polymerase gene
according to the manufacturer's protocol (Novagen). The mutant GreA
and GreB factors were purified to apparent homogeneity using the same
purification scheme as described for wt GreA and
His6-tagged wt GreB (49) with minor modifications (35).
Electrophoretically homogeneous Gre proteins were stored at 10 mg/ml in
storage buffer (40 mM Tris-HCl, pH 7.9, 0.8 M
NaCl, 50% glycerol, 0.1 mM EDTA, 5 mM
2-mercaptoethanol) at
20 °C.
. The initial TEC
carrying radiolabeled hexameric transcript
CpApCpCpApC (6C-TEC) was prepared by
incubation of 0.9 µg (7.3 pmol) of the DNA fragment with 12 µg (30 pmol) of GreA/GreB-free RNAP holoenzyme (10), 1 mg/ml bovine serum
albumin, 0.5 mM CpA, 5 µM ATP, and 1 µM [
-32P]CTP (3000 Ci/mmol) in 35 µl
of standard transcription buffer (40 mM Tris-acetate, pH
7.9, 30 mM KCl, and 10 mM MgCl2)
for 10 min at 37 °C (here and elsewhere in the text, boldface type
symbolizes radioactive phosphates). The 6C-TEC was further purified by
gel filtration on Quick-Spin G-50 column. The TEC carrying heptamer CpApCpCpApCpU (7U-TEC), nonamer
CpApCpCpApCpUpGpA (9A-TEC), and
arrested TECs carrying 12-meric and 13-meric transcripts CpApCpCpApCpUpGpApCpApC(pG)
(12C/13G-TEC) were obtained as described (49) by extension of 6C-TEC in
the presence of UTP (3 µM), UTP+GTP+ATP (5 µM each) and four rNTPs (30 µM each),
respectively, followed by purification on Quick-Spin G-50 column. The
TEC carrying decamer
CpApCpCpApCpUpGpApC (10C-TEC) was
obtained by extension of purified 9A-TEC in the presence of 10 µM CTP (2). For the analysis of the type of cleavage
activity of Gre factors, 9A- and 10C-TECs carrying radioactive phosphate at position +9 were prepared from unlabeled 6C-TEC (2). First, 6C-TEC was extended in the presence of 2 µM each
of UTP + GTP + [
-32P]ATP (1500 Ci/mmol) yielding
9A-TEC, which was purified by Quick-Spin G-50 column. Then, the
radiolabeled 9A-TEC was extended in the presence of 10 µM
CTP yielding 10C-TEC. For determination of specific transcript cleavage
activity of Gre mutants (as well as their antiarrest/readthrough
activities), we used procedures that are described in our previous
publications (1, 2, 10, 34, 35, 49). Briefly, for each Gre protein, the
specific cleavage activity was determined by measuring the percentage
of cleavage of the initial 2.5 nM TEC after incubation with
serial 3-fold dilutions of Gre factor in 10 µl of standard
transcription buffer at 37 °C for 20 min (49). The titration curves
were made for each Gre protein, and the minimum amount of factor that
causes 50% hydrolysis of RNA in the corresponding TEC was calculated. Similarly, for determination of specific readthrough activity, the
initial radiolabeled 2.5 nM 6C-TEC was incubated in the
presence of 100 µM NTPs with serial dilutions of Gre
proteins as described above, and the minimum amount of factor that is
required to decrease the formation of arrested 12C/13G-TECs by 50% was
calculated (49). The RNA products were analyzed by urea-23%-PAGE,
autoradiographed and quantified using a PhosphorImager as described
(34).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (117K):
[in a new window]
Fig. 1.
Sequence alignment of the N-terminal domain
of Gre proteins from 33 different organisms (see text for
details). The Gre gene sequences that were obtained from published
sources are referenced (2, 38-48). Sequence data for all other Gre
genes was obtained using the BLAST search engine from NCBI, The
Institute for Genomic Research, and the Sanger Center. The groups that
provided the sequence data are identified by a capital letter after
each organism as follows: O, Oklahoma University Advanced
Center for Genome Technology; S, Pathogen Sequencing Unit at
the Sanger Center; T, The Institute for Genomic Research;
G, Genome Therapeutics Corp.; P, University of
Washington Genome Center and PathoGenesis Corp. GenBankTM
accession numbers for the GreA genes of Rhizobium
leguminosarum and Zymomonas mobilis and the GreB gene
of Yersinia enterocolitica are G2944085, G2654150, and
Y08950, respectively. The numbering above the sequences is
with reference to E. coli GreA. The sequences in open
red box (also indicated by horizontal red brackets)
denote the fragments of E. coli GreA and GreB containing the
cross-link with RNA 3'-terminus (33, 34). Identical amino acid residues
are shown in gray. Conserved residues forming basic patches of GreA and
GreB are shown in blue boxes.
List of Gre mutants

View larger version (44K):
[in a new window]
Fig. 2.
Quantitative in vitro
analysis of BPL Gre mutants. A, water-accessible
surface and charge distribution of wt and mutant Gre factors generated
using GRASP (52) based on published crystal structure of GreA (33) and
model structure of GreB (34). The surface is colored by the
electrostatic potential: white, uncharged; red,
negative (Asp and Glu); blue, positive (Arg and Lys). The
side of the protein that presumably faces the RNAP and RNA in TECs is
shown. B, the transcript cleavage assay toward 7U-, 9A-,
10C-, and 12C/13G-TECs. The bar graphs, shown in logarithmic
scale, represent the specific activities of Gre proteins expressed in
relative units/µg (34, 51). Each value represents an average of at
least three independent experiments. C, the
photocross-linking and transcription readthrough assays. The
light gray bars represent the efficiency of specific RNA-Gre
cross-linking expressed in arbitrary units/µg. 1 unit is defined as
0.05 fmol of the radioactive 9A-TEC cross-linked to GreA and GreB under
standard reaction conditions (34). All proteins were titrated over a
wide range of concentrations (10 nM to 20 µM)
to obtain the specific values of cross-linking efficiency within the
linear range of concentrations. The black bars represent the
specific readthrough activities of Gre proteins expressed in relative
units/µg (34, 51). Each value represents an average of three
independent experiments.
GreA-37A
GreA-52A
GreA-BPL, and for GreB mutants in the order GreB > GreB-BPL2
GreB-BPL-4
GreB-BPL5
GreB-BPL5-DD. The strongest negative effect was observed with GreA-BPL and GreB-BPL5-DD, the cross-linking efficiencies of which were 4 and 0.2% of the
cross-linking efficiencies of wt GreA and GreB, respectively. To test
whether this result reflects a general failure of Gre mutants to bind 9A-TEC, we performed a similar cross-linking experiment using a
photoactive probe 5-(4-azido-2-nitrophenyl)-allylamino derivative of
UMP (N3-NPA-UMP) with a long spacer (~12 Å) incorporated
at position +7 of the transcript in 9A-TEC (35). N3-NPA-UMP
has a wider radius of action than 8-N3-AMP and allows us to
detect the presence of Gre factors in TEC without being as
discriminating as 8-N3-AMP (33, 34). Gre mutants lacking
basic patch cross-linked with 9A-TEC carrying N3-NPA-UMP
with the same efficiency as the wt factors (data not shown), indicating
that the binding affinity of Gre proteins toward 9A-TEC was not
affected by basic patch mutations. Therefore, the strength of specific
RNA-Gre interactions in TEC appears to be a direct function of the size
and the overall charge of the basic patch on the surface of NTD.
GreA-37A
GreA-52A
GreA-BPL, and GreB > GreB-BPL2
GreB-BPL-4
GreB-BPL5
GreB-BPL5-DD. Again, the most severe defect was observed in
proteins completely lacking basic patch: GreA-BPL and GreB-BPL5-DD (25- and 450-fold decreases, respectively). A similar loss of activity was
observed for GreB mutants in their antiarrest activity (49), namely the
ability of Gre factors to reactivate preformed arrested 12C- and
13G-TECs (data not shown). These observations imply a functional
correlation between the property of Gre proteins to interact with RNA
and their readthrough/antiarrest activities.

View larger version (40K):
[in a new window]
Fig. 3.
Analysis of the type of cleavage activity of
BPL Gre mutants toward 9A-TEC (A) and 10C-TEC
(B). Shown are the autoradiographs after
urea-23%-PAGE. A, the starting 9A-TEC (2 nM)
(lane 1) was incubated in transcription buffer for 10 min at
37 °C alone (lane 2) or in the presence of 20 nM Gre factors (lanes 3-11) as indicated.
B, the initial 10C-TEC (1 nM) (lane
1) was incubated in transcription buffer for 15 min at 37 °C in
the presence of 50 nM Gre factors (lanes 2-7)
as indicated. The asterisk indicates radioactive
phosphates.

View larger version (45K):
[in a new window]
Fig. 4.
In vitro analysis of GreA mutants
carrying large basic patch. All details of the figure are as
described in Fig. 2.
helices of the coiled-coil domain (34). The nicked
GreB displays ~10 times higher efficiency of photocross-linking to RNA 3'-terminal probe in 9A-TEC, but ~200-times lower transcript cleavage activity toward 7U- and 9A-TECs, than the intact factor and
completely lacks antiarrest and readthrough activities (data not
shown). As in the case of GreA-LBP4 mutant, the distortion of the
coiled-coil structure of NTD in GreB, caused by a nick in the
polypeptide chain, results in an aberrant RNA binding and loss of
functional activity.

View larger version (85K):
[in a new window]
Fig. 5.
In vivo analysis of BPL-GreA
mutants. A, Coomassie staining after Tris-Tricine
SDS-16%-PAGE of the total cell lysates of
greA-/greB- E. coli strain containing vector alone (lane 1) or
plasmids expressing wt GreA (lanes 2-5), GreA-37A
(lanes 6-9), GreA-52A (lanes 10-13), and
GreA-BPL (lanes 14-17). Cells were induced by 0.03 mM (lanes 3, 7, 11, and 15), 0.1 mM (lanes 4, 8, 12, and 16), and 0.3 mM (lanes 1, 5, 9, 13, and 17) IPTG.
The arrow indicates the position of expressed Gre protein on
the gel. B, photograph of cultures grown on LB-agar medium
under conditions specified in the figure and under "Materials and
Methods." The numbers at the top of panels a-c
indicate the number of cells/ml.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
'-subunit
and parts of conserved regions
'-E and
'-G. In this case, the
basic patch of the NTD will be placed in close proximity to region
'-G, in which the cross-linking to the nascent RNA 3'-terminus has
been observed in backtracked TECs (54, 55).
:GreB- E. coli strain.
Together with our in vitro data, this indicates that basic
patch interactions with nascent transcript are important for the
in vivo functions of Gre proteins. However, these
interactions can be detrimental to the cell if TECs become
oversaturated with Gre protein, because we observed toxic effects after
overexpression of wt GreA. It is not the binding of Gre to TEC
per se but rather its functional interactions with TEC that
cause the toxic effect(s). This is based on the observation that the
GreA-BPL mutant that binds TEC normally but have reduced RNA binding
and readthrough activity did not confer a toxic effect when
overexpressed (Fig. 5B). The observed toxicity may result
from the reduced rate of transcription elongation and incomplete
transcription of vital genes due to overstimulation of RNAP
endonuclease activity. GreA lacking just one basic residue
(Arg52 or Arg37) conferred a partial or full
complementation of ts phenotype under low and high levels of
expression, respectively. These results are in keeping with the fact
that in some bacterial organisms, GreA has only one basic residue in
its basic patch (Fig. 1). In addition, an interesting correlation was
observed between the readthrough activity of GreA-BPL mutants and their
in vivo phenotypes. The impairment of readthrough activity
of GreA mutants observed in vitro almost quantitatively
parallels their loss of ability to complement the ts phenotype of
greA-/greB
strain
(Fig. 5). These results suggest that in vivo functions of
Gre factors involve, at least in part, the readthrough activity of Gre
proteins observed in vitro.
| |
ACKNOWLEDGEMENTS |
|---|
We thank M. Anikin for helpful discussion and A. Mustaev for providing the photocross-linking reagent.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grants GM54098 (to S. B.) and GM28946 (to A. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Present address: Dept. of Biochemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
** To whom correspondence should be addressed: Dept. of Microbiology and Immunology, State University of New York, Health Science Center at Brooklyn, 450 Clarkson Ave., BSB 3-27, Brooklyn, NY 11203. Tel.: 718-270-3752; Fax: 718-270-2656; E-mail: serbor@asan.com.
2 D. Kulish, unpublished data.
3 I. Lomakin and D. Kulish, unpublished observation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
SII, transcription
elongation factor TFIIS;
RNAP, RNA polymerase;
TEC, ternary elongation
complex;
CTD, C-terminal globular domain;
NTD, N-terminal coiled-coil
domain;
BPL, basic patch-less;
LBP, large basic patch;
8-N3AMP, 8-azidoadenosine monophosphate;
N3-NPA-UMP, 5-(4-azido-2-nitrophenyl)-allylaminouridine
monophosphate;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine;
ts, temperature sensitivity;
wt, wild type;
PAGE, polyacrylamide gel
electrophoresis;
IPTG, isopropyl-
-
D-thiogalactopyranoside.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Borukhov, S.,
Polyakov, A.,
Nikiforov, V.,
and Goldfarb, A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
8899-8902 |
| 2. | Borukhov, S., Sagitov, V., and Goldfarb, A. (1993) Cell 72, 459-466[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Reines, D.,
Chamberlin, M. J.,
and Kane, C. M.
(1989)
J. Biol. Chem.
264,
10799-10809 |
| 4. |
Izban, M. G.,
and Luse, D. S.
(1992)
Genes Dev.
6,
1342-1356 |
| 5. |
Reines, D.
(1992)
J. Biol. Chem.
267,
3795-3800 |
| 6. | Reines, D., Ghanouni, P., Gu, W., Mote, J., Jr., and Powell, W. (1993) Cell. Mol. Biol. Res. 39, 331-338[Medline] [Order article via Infotrieve] |
| 7. |
Guo, H.,
and Price, D. H.
(1993)
J. Biol. Chem.
268,
18762-18770 |
| 8. | Hawley, D. K., Wiest, D. K., Holtz, M. S., and Wang, D. (1993) Cell. Mol. Biol. Res. 39, 339-348[Medline] [Order article via Infotrieve] |
| 9. |
Surratt, C. K.,
Milan, S. C.,
and Chamberlin, M. J.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7983-7987 |
| 10. |
Orlova, M.,
Newlands, J.,
Das, A.,
Goldfarb, A.,
and Borukhov, S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4596-4600 |
| 11. |
Hagler, J.,
and Shuman, S.
(1993)
J. Biol. Chem.
268,
2166-2173 |
| 12. |
Tschochner, H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12914-12919 |
| 13. |
Whitehall, S. K.,
Bardeleben, C.,
and Kassavetis, G. A.
(1994)
J. Biol. Chem.
269,
2299-2306 |
| 14. |
Ahn, B. Y.,
Gershon, P. D.,
Jones, E. V.,
and Moss, B.
(1990)
Mol. Cell. Biol.
10,
5433-5441 |
| 15. |
Langer, D.,
and Zillig, W.
(1993)
Nucleic Acids Res.
21,
2251 |
| 16. |
Sawadogo, M.,
Sentenac, A.,
and Fromageot, P.
(1980)
J. Biol. Chem.
255,
12-15 |
| 17. |
Sluder, A. E.,
Greenleaf, A. L.,
and Price, D. H.
(1989)
J. Biol. Chem.
264,
8963-8969 |
| 18. |
Reinberg, D.,
and Roeder, R. G.
(1987)
J. Biol. Chem.
262,
3331-3337 |
| 19. |
Rappaport, J.,
Reinberg, D.,
Zandomeni, R.,
and Weinmann, R.
(1987)
J. Biol. Chem.
262,
5227-5232 |
| 20. |
Archambault, J.,
Lacroute, F.,
Ruet, A.,
and Friesen, J. D.
(1992)
Mol. Cell. Biol.
12,
4142-4152 |
| 21. |
Feng, G. H.,
Lee, D. N.,
Wang, D.,
Chan, C. L.,
and Landick, R.
(1994)
J. Biol. Chem.
269,
22282-22294 |
| 22. |
Gu, W.,
and Reines, D.
(1995)
J. Biol. Chem.
270,
30441-30447 |
| 23. |
Rudd, M. D.,
Izban, M. G.,
and Luse, D. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8057-8061 |
| 24. | Uptain, S. M., Kane, C. M., and Chamberlin, M. J. (1997) Annu. Rev. Biochem. 66, 117-172[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Nudler, E., Mustaev, A., Lukhtanov, E., and Goldfarb, A. (1997) Cell 89, 33-41[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Komissarova, N.,
and Kashlev, M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1755-1760 |
| 27. | Reeder, T. C., and Hawley, D. K. (1996) Cell 87, 767-777[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
von Hippel, P. H.
(1998)
Science
281,
660-665 |
| 29. |
Erie, D. A.,
Hajiseyedjavadi, O.,
Young, M. C.,
and von Hippel, P. H.
(1993)
Science
262,
867-873 |
| 30. | Kassavetis, G. A., and Geiduschek, E. P. (1993) Science 259, 944-945[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Jeon, C.,
and Agarwal, K.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13677-13682 |
| 32. |
Hsu, M. H.,
Vo, N. V.,
and Chamberlin, M. J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11588-11592 |
| 33. | Stebbins, C. E., Borukhov, S., Orlova, M., Polyakov, A., Goldfarb, A., and Darst, S. A. (1995) Nature 373, 636-640[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Koulich, D.,
Orlova, M.,
Malhotra, A.,
Sali, A.,
Darst, S. A.,
Goldfarb, A.,
and Borukhov, S.
(1997)
J. Biol. Chem.
272,
7201-7210 |
| 35. | Koulich, D., Nikiforov, V., and Borukhov, S. (1998) J. Mol. Biol. 276, 379-389[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Polyakov, A., Richter, C., Malhotra, A., Koulich, D., Borukhov, S., and Darst, S. A. (1998) J. Mol. Biol. 281, 262-266 |
| 37. |
Loizos, N.,
and Darst, S. A.
(1999)
J. Biol. Chem.
274,
23378-23386 |
| 38. |
Sparkowski, J.,
and Das, A.
(1990)
Nucleic Acids Res.
18,
6443 |
| 39. |
Fleischmann, R. D.,
Adams, M. D.,
White, O.,
Clayton, R. A.,
Kirkness, E. F.,
Kerlavage, A. R.,
Bult, C. J.,
Tomb, J.-F.,
Dougherty, B. A.,
Merrick, J. M.,
McKenney, K.,
Sutton, G.,
FitzHugh, W.,
Fields, C.,
Gocayne, J. D.,
Scott, J.,
Shirley, R.,
Liu, L.-I.,
Glodek, A.,
Kelley, J. M.,
Weidman, J. F.,
Phillips, C. A.,
Spriggs, T.,
Hedblom, E.,
Cotton, M. D.,
Utterback, T. R.,
Hanna, M. C.,
Nguyen, D. T.,
Saudek, D. M.,
Brandon, R. C.,
Fine, L. D.,
Fritchman, J. L.,
Fuhrmann, J. L.,
Geoghagen, N. S. M.,
Gnehm, C. L.,
McDonald, L. A.,
Small, K. V.,
Fraser, C. M.,
Smith, H. O.,
and Craig Venter, J.
(1995)
Science
269,
496-511 |
| 40. |
Marks, G. L.,
and Wood, D. O.
(1992)
Nucleic Acids Res.
20,
3785 |
| 41. |
Fraser, C. M.,
Gocayne, J. D.,
White, O.,
Adams, M. D.,
Clayton, R. A.,
Fleischmann, R. D.,
Bult, C. J.,
Kerlavage, A. R.,
Sutton, G.,
Kelley, J. M.,
Fritchman, J. L.,
Weidman, J. F.,
Small, K. V.,
Sandusky, M.,
Fuhrmann, J.,
Nguyen, D.,
Utterback, T. R.,
Saudek, D. M.,
Phillips, C. A.,
Merrick, J. M.,
Tomb, J.-F.,
Dougherty, B. A.,
Bott, K. F.,
Hu, P.-C.,
Lucier, T. S.,
Peterson, S. N.,
Smith, H. O.,
Hutchison, C. A., III,
and Venter, J. C.
(1995)
Science
270,
397-403 |
| 42. | Kunst, F., Ogasawara, N., Moszer, I., Albertini, A. M., Alloni, G., Azevedo, V., Bertero, M. G., Bessieres, P., Bolotin, A., Borchert, S., Borriss, R., Boursier, L., Brans, A., Braun, M., Brignell, S. C., Bron, S., Brouillet, S., Bruschi, C. V., Caldwell, B., Capuano, V., Carter, N. M., Choi, S. K., Codani, J. J., Connerton, I. F., Cummings, N. J., et al.. (1997) Nature 390, 249-256[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Fraser, C. M., Casjens, S., Huang, W. M., Sutton, G. G., Clayton, R., Lathigra, R., White, O., Ketchum, K. A., Dodson, R., Hickey, E. K., Gwinn, M., Dougherty, B., Tomb, J. F., Fleischmann, R. D., Richardson, D., Peterson, J., Kerlavage, A. R., Quackenbush, J., Salzberg, S., Hanson, M., van Vugt, R., Palmer, N., Adams, M. D., Gocayne, J., Weideman, J., et al.. (1997) Nature 390, 580-586[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Stephens, R. S.,
Kalman, S.,
Lammel, C.,
Fan, J.,
Marathe, R.,
Aravind, L.,
Mitchell, W.,
Olinger, L.,
Tatusov, R. L.,
Zhao, Q.,
Koonin, E. V.,
and Davis, R. W.
(1998)
Science
282,
754-759 |
| 45. | Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., III, Tekaia, F., Badcock, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R., Devlin, K., Feltwell, T., Gentles, S., Hamlin, N., Holroyd, S., H |